Trails Edge Capital Partners, LP - 11 Aug 2025 SCHEDULE 13G Report for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR)

Filing Manager
Trails Edge Capital Partners, LP
Reporting Manager
Trails Edge Capital Partners, LP
Security
X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
XFOR
Shares outstanding
23,405,586 shares
Disclosed Ownership
2,317,153 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
18 Aug 2025, 17:00:18 UTC
Date of event
11 Aug 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 9.9% 2,317,153 2,317,153 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 9.9% 2,317,153 2,317,153 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 9.9% 2,317,153 2,317,153 0 /s/ Ortav Yehudai Ortav Yehudai / Individual